Market Overview

Flexion Therapeutics (NASDAQ: FLXN)

11.02 +0.50 (4.75%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/20/20Goldman SachsInitiates Coverage OnNeutral15.0
7/31/20OppenheimerInitiates Coverage OnOutperform19.0
7/29/20Credit SuisseInitiates Coverage OnOutperform19.0
6/25/20HC Wainwright & Co.Initiates Coverage OnBuy25.0
5/27/20GuggenheimInitiates Coverage OnBuy20.0
5/08/20NeedhamMaintainsBuy20.0
5/08/20RBC CapitalMaintainsOutperform18.0
4/30/20NeedhamMaintainsBuy30.0
4/27/20Raymond JamesMaintainsStrong Buy20.0
4/02/20BenchmarkMaintainsBuy17.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter